Dual binding site inhibitors of B-RAF kinase

Bioorg Med Chem Lett. 2008 May 1;18(9):2825-9. doi: 10.1016/j.bmcl.2008.04.002. Epub 2008 Apr 4.

Abstract

Computer aided modeling guided the design of a series of diarylimidazole compounds (11-22) intended to interact with both the ATP and adjacent allosteric binding domains of B-RAF kinase. Their ability to inhibit the function of B-RAF kinase and intracellular ERK1/2 phosphorylation were evaluated.

MeSH terms

  • Adenosine Triphosphate / metabolism
  • Allosteric Site
  • Computer-Aided Design*
  • Crystallography, X-Ray
  • Extracellular Signal-Regulated MAP Kinases / antagonists & inhibitors
  • Hydrocarbons, Aromatic / chemical synthesis
  • Hydrocarbons, Aromatic / pharmacology*
  • Imidazoles / chemical synthesis
  • Imidazoles / pharmacology*
  • Inhibitory Concentration 50
  • Phosphorylation / drug effects
  • Protein Kinase Inhibitors / chemical synthesis
  • Protein Kinase Inhibitors / pharmacology*
  • Proto-Oncogene Proteins B-raf / antagonists & inhibitors*
  • Structure-Activity Relationship

Substances

  • Hydrocarbons, Aromatic
  • Imidazoles
  • Protein Kinase Inhibitors
  • Adenosine Triphosphate
  • Proto-Oncogene Proteins B-raf
  • Extracellular Signal-Regulated MAP Kinases